Sustained therapeutic effects of oral miglustat (Zavesca,N-butyldeoxynojirimycin, OGT 918) in type I Gaucher disease

✍ Scribed by D. Elstein; C. Hollak; J. M. F. G. Aerts; S. van Weely; M. Maas; T. M. Cox; R. H. Lachmann; M. Hrebicek; F. M. Platt; T. D. Butters; R. A. Dwek; A. Zimran

• Book ID: 111574794
• Publisher: Springer
• Year: 2004
• Tongue: English
• Weight: 238 KB
• Volume: 27
• Category: Article
• ISSN: 0141-8955
• DOI: 10.1023/b:boli.0000045756.54006.17